WO2019100726A1 - Application of d dna tetrahedron in promoting proliferation and differentiation of neural stem cells - Google Patents
Application of d dna tetrahedron in promoting proliferation and differentiation of neural stem cells Download PDFInfo
- Publication number
- WO2019100726A1 WO2019100726A1 PCT/CN2018/094561 CN2018094561W WO2019100726A1 WO 2019100726 A1 WO2019100726 A1 WO 2019100726A1 CN 2018094561 W CN2018094561 W CN 2018094561W WO 2019100726 A1 WO2019100726 A1 WO 2019100726A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stem cells
- neural stem
- differentiation
- promoting
- proliferation
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides, bases
Definitions
- the invention belongs to the technical field of cell proliferation and differentiation, and particularly relates to the application of a DNA tetrahedron in promoting the proliferation and differentiation of neural stem cells.
- Mouse neural stem cells which are derived from the ATCC cell bank, are one of the better models for studying the nervous system in vitro.
- the NE-4C cell line can maintain the characteristics of neural stem cells under certain circumstances, but can differentiate into mature neurons or glial cells after specific induction treatment.
- the main direction is to study the effects of drugs or materials on the proliferation and differentiation of neural stem cells, such as the proliferation and differentiation of prostaglandin neural stem cells; and neural stem cells in some central degenerative diseases.
- Cellular therapeutic effects such as the therapeutic role of neural stem cells in animal models of Alzheimer's disease.
- TDNs DNA tetrahedral nanomaterials
- S1, S2, S3, S4 The base sequences of four ss DNAs (S1, S2, S3, S4) strictly follow the "base complementary pairing". The principle is then precisely and subtly designed.
- TDNs The synthesis method of TDNs is simple, the yield is high, and the tolerance to specific or non-specific nucleases is better than that of ordinary linear DNA, and it has good biocompatibility, biosafety and biodegradability.
- TDNs there are many studies on TDNs, there are few studies on the effects of various physiological activities on cells, especially the research on promoting cell proliferation and differentiation.
- the present invention provides a DNA tetrahedron for promoting proliferation and differentiation of neural neural stem cells by affecting Wnt/ ⁇ -catenin and Notch signaling pathway-related genes and proteins. Expression changes, respectively, to promote the proliferation and differentiation of neural stem cells.
- DNA tetrahedron in promoting proliferation and differentiation of neural stem cells, D, wherein the four single-stranded sequences of DNA tetrahedra are as shown in SEQ ID NO: 1-4.
- DNA tetrahedron promotes proliferation of neural stem cells by activating Wnt/ ⁇ -catenin signaling pathway; DNA tetrahedron promotes differentiation of neural stem cells by inhibiting Notch signaling pathway.
- the process of promoting neural stem cell proliferation includes promoting the expression of ⁇ -catenin, Lef-1, and Cyclin-D proteins.
- the process of promoting neural stem cell proliferation includes promoting the expression of the ⁇ -catenin, Lef-1, and Cyclin-D genes.
- the process of promoting differentiation of neural stem cells includes reducing the expression of Notch-1, Hes-1 and Hes-5 proteins.
- the process of promoting differentiation of neural stem cells comprises promoting expression of a ⁇ -III-Tubulin protein.
- the processes of promoting differentiation of neural stem cells include inhibition of expression of Notch-1, Hes-1 and Hes-5 genes, respectively, and promotion of expression of ⁇ -III-Tubulin gene.
- the concentration of the DNA tetrahedron in promoting proliferation and differentiation of the neural stem cells is 50 to 500 nM.
- the concentration of the DNA tetrahedron in promoting proliferation and differentiation of the neural stem cells is 100 to 300 nM.
- the concentration of the DNA tetrahedron in promoting proliferation and differentiation of neural stem cells was 250 nM.
- TDNs have good biocompatibility, biosafety and biodegradability, they can effectively solve the problem of poor biological performance of traditional drugs or materials.
- DNA tetrahedron (TDNs) nanomaterials promote the proliferation and differentiation of neural stem cells, and at the same time solve the problems of slower proliferation of neural stem cells and slower differentiation and maturation, which lays a certain foundation for subsequent in vivo neural stem cell therapy experiments. Research basis.
- DNA tetrahedrons can promote the proliferation and differentiation process by regulating Wnt/ ⁇ -catenin and Notch signaling pathways, respectively, by promoting the expression of ⁇ -catenin, Lef-1 and Cyclin-D genes and proteins. Promote the proliferation of mouse neural stem cells; by reducing the expression of Notch-1, Hes-1 and Hes-5 proteins, and promoting the expression of ⁇ -III-Tubulin genes and proteins, the purpose of promoting differentiation of mouse neural stem cells can be achieved.
- FIG. 1 is a schematic representation of four single-stranded synthetic TDNs.
- FIG. 2 is a schematic diagram showing the results of TDNs polyacrylamide gel electrophoresis.
- Figure 3 is a schematic illustration of the results of transmission electron microscopy identification.
- Fig. 4 is a diagram showing the results of identifying the undifferentiated state of mouse neural stem cells by immunofluorescence technique.
- Figure 5 is a graphical representation of the results of detection of TDNS uptake by mouse neural stem cells using fluorescent tracing techniques.
- Figure 6 is a graphical representation of the results of the effect of TDNs concentration on the proliferation of mouse neural stem cells.
- Figure 7 is a graph showing the results of cell cycle changes of mouse neural stem cells under the action of TDNs by flow cytometry.
- Fig. 8 (a), (b) and (c) are schematic diagrams showing the detection of the expression levels of ⁇ -catenin, Lef-1 and Cyclin-D genes and proteins in mouse neural stem cells under the action of TDNs.
- Fig. 9 (a), (b) and (c) are schematic diagrams showing the detection of ⁇ -III-Tubulin gene and protein expression in mouse neural stem cells under the action of TDNs.
- Figures 10 and 11 are diagrams showing the results of detecting the expression level of ⁇ -III-Tubulin protein by immunofluorescence technique.
- Fig. 12 (a), (b) and (c) are schematic diagrams showing the detection of the expression levels of Notch-1, Hes-1, Hes-5 genes and proteins in mouse neural stem cells under the action of TDNs.
- TDNs DNA Tetrahedrons
- Polyacrylamide gel was prepared by using 40% acrylamide, 10 ⁇ TAE, 10% APS solution, distilled water and TEMED;
- the four single-stranded S1, S2, S3 and S4 sizes of TDNs are about 60 bp, 50 bp, 50 bp and 50 bp, respectively, and the size of TDNs is about 210 bp.
- TDNs were identified by transmission electron microscopy. The results are shown in Fig. 3. As shown in Fig. 3, the shape of TDNs (triangular) is approximately triangular in shape under transmission electron microscopy, and the particle size is about 10-15 nM. The circle is labeled as a polymer.
- the cell suspension was inoculated into a confocal dish and placed in an incubator for 24 hours.
- the medium containing DMEM + 10% serum + 1% double antibody was aspirated, and washed three times with PBS for 5 minutes each time;
- Triton-100 treatment for 20-25 minutes, aspirate Triton-100, wash 3 times with PBS for 5 minutes each time;
- the sheep serum was treated for 1 hour, the sheep serum was aspirated, and the PBS was washed 3 times for 5 minutes each time;
- Phalloidin treatment protected from light, 10-30 minutes, aspirate phalloidin, wash 3 times in PBS for 5 minutes each time;
- DAPI treatment protected from light, 10 minutes, aspirate DAPI, wash 3 times with PBS for 5 minutes each time.
- 10% glycerol seal protected from light, stored at 4 ° C. Check on the machine.
- Fig. 4 The detection results are shown in Fig. 4. As shown in Fig. 4, the mouse neural stem cells showed that the nestin antibody was positive, indicating that the cells were still in an undifferentiated state, and could be used for subsequent proliferation and differentiation experiments.
- the cultured cell suspension was divided into a control group and an experimental group.
- the concentration of 250 nM was added to the control group, and the Cy-5-modified DNA single-stranded S1 was added.
- the experimental group was added at a concentration of 250 nM and modified with Cy-5.
- the TDNs were cultured in an incubator for 6 hours (37 ° C, 5% CO 2 ).
- single-stranded S1 is less taken up by neural stem cells; neural stem cells take up more TDNs, and most of the TDNs that enter the cells accumulate in the cytoplasm of the cells and enter the nucleus less.
- the cultured cell suspension was divided into a control group and an experimental group, and TDNs were added to the experimental group, and an equal amount of PBS was added to the control group, followed by incubation in an incubator for 24 hours (37 ° C, 5% CO 2 ). ).
- TDNs As shown in Fig. 6, when the concentration of TDNs was 62.5 nM, 125 nM, and 250 nM, the proliferation process of mouse neural stem cells in the experimental group was promoted to a certain extent by TDNs, and 250 nM was the most. Good concentration indicates that TDNs have the effect of promoting the proliferation of mouse neural stem cells.
- the cultured cell suspension was divided into a control group and an experimental group, and TDNs were added to the experimental group, and an equal amount of PBS was added to the control group, followed by incubation in an incubator for 24 hours (37 ° C, 5% CO 2 ). ).
- control cells and the experimental group cells were separately digested with 0.25% trypsin, placed in a 15 ml centrifuge tube (2000 rpm, 5 minutes), the supernatant was discarded, washed with PBS, centrifuged (2000 rpm, 5 minutes), and then added with ice. 500 ⁇ l of ethanol was fixed, and the cells were fixed at 4 ° C overnight. The next day, PBS was added to centrifuge, the supernatant was discarded, washed with PBS, centrifuged, and the supernatant was discarded. Then, 100 ⁇ l of RNase was added, and a 37 ° C water bath was added for 30 minutes. 400 ⁇ l of PI was added and mixed. Protected from light at 4 ° C for 30 minutes. The cells were transferred to a flow tube, detected by the machine, and analyzed by data. The results are shown in Fig. 7.
- the number of cells in the S phase (DNA synthesis phase) in the experimental group increased significantly, indicating that TDNs changed the cell cycle of neural stem cells and promoted its proliferation.
- the three proteins in the Wnt/ ⁇ -catenin signaling pathway associated with the neural stem stem cell proliferation process in the experimental group were ⁇ -catenin, respectively.
- Lef-1 and Cyclin-D the expression levels of three proteins and corresponding control genes were increased by ⁇ -catenin, Lef-1 and Cyclin-D, further indicating that TDNs promoted the proliferation of neural stem cells.
- the suspension cells were divided into control group and experimental group, and TDNs at a concentration of 250 nM were added to the experimental group.
- the same amount of PBS was added to the control group, and then cultured in an incubator for 24 hours (37 ° C, 5%). CO 2 ), then the gene extraction kit was used to extract the control and experimental group genes, respectively, and then the stable cDNA was obtained by the high purity total RNA rapid extraction kit and the reverse transcription kit.
- the three proteins in the Wnt/ ⁇ -catenin signaling pathway associated with neural stem cell proliferation in the experimental group were ⁇ -catenin, Lef-1, and Cyclin-, respectively.
- D the expression levels of the three proteins and the corresponding control genes ⁇ -catenin, Lef-1 and Cyclin-D were increased, further indicating that TDNs promoted the proliferation of neural stem cells.
- the expression levels of the differentiation-related protein ( ⁇ -III-Tubulin) in the experimental group were higher than those in the control group.
- the expression levels of Notch-1, Hes-1 and Hes-5 were decreased in the three proteins related to the Notch signaling pathway in the experimental group, indicating that TDNs can promote the differentiation of mouse neural stem cells. mature.
- (1) Inoculate the cell suspension (100 ⁇ l/well) in a 6-well plate, place the plate in an incubator for 24 hours (37 ° C, 5% CO 2 ), and then the component is DMEM+
- the serum concentration in the medium of 10% serum + 1% double antibody was reduced from 10% to 6%, cultured in the incubator for 6 hours (37 ° C, 5% CO 2 ), and then the serum concentration in the medium was 6 % was lowered to 0 and incubated for 1 hour in the incubator (37 ° C, 5% CO 2 ).
- the expression level of the differentiation-related gene ( ⁇ -III-Tubulin) in the experimental group was higher, and compared with the control group,
- the three proteins on the Notch signaling pathway in the differentiation group were Notch-1, Hes-1 and Hes-5, and the expression levels of the corresponding genes Notch-1, Hes-1 and Hes-5 were decreased.
- TDNs can promote the differentiation and maturation of mouse neural stem cells.
- the cell suspension obtained in the step (1) is cultured in a medium containing DMEM/F-12+1% double antibody + 1% B27, and the cell suspension is divided into a control group and an experimental group, and each day. At the same time, the medium was changed; TDNs at a concentration of 250 nM were added to the experimental group, and an equal amount of PBS was added to the control group for 1 day and 7 days.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
- DNA四面体在促进神经干细胞增殖分化过程中的应用,其中,DNA四面体的四条单链序列如SEQ ID NO:1-4所示。The application of the DNA tetrahedron in promoting the proliferation and differentiation of neural stem cells, wherein the four single-stranded sequences of the DNA tetrahedron are shown in SEQ ID NOs: 1-4.
- 根据权利要求1所述的DNA四面体在促进神经干细胞增殖分化过程中的应用,其特征在于,所述DNA四面体促进神经干细胞的增殖是通过激活Wnt/β-catenin信号通路发挥作用的;所述DNA四面体促进神经干细胞的分化是通过抑制Notch信号通路发挥作用的。The use of the DNA tetrahedron according to claim 1 for promoting proliferation and differentiation of neural stem cells, characterized in that said DNA tetrahedron promotes proliferation of neural stem cells by activating Wnt/β-catenin signaling pathway; The DNA tetrahedron promotes differentiation of neural stem cells by inhibiting the Notch signaling pathway.
- 根据权利要求2所述的DNA四面体在促进神经干细胞增殖分化过程中的应用,其特征在于,促进神经干细胞增殖的过程包括促进β-catenin、Lef-1和Cyclin-D蛋白的表达。The use of the DNA tetrahedron according to claim 2 for promoting proliferation and differentiation of neural stem cells, characterized in that the process of promoting proliferation of neural stem cells comprises promoting expression of β-catenin, Lef-1 and Cyclin-D proteins.
- 根据权利要求2所述的DNA四面体在促进神经干细胞增殖分化过程中的应用,其特征在于,促进神经干细胞增殖的过程包括促进β-catenin、Lef-1和Cyclin-D基因的表达。The use of the DNA tetrahedron according to claim 2 for promoting proliferation and differentiation of neural stem cells, characterized in that the process of promoting proliferation of neural stem cells comprises promoting expression of β-catenin, Lef-1 and Cyclin-D genes.
- 根据权利要求2所述的DNA四面体在促进神经干细胞增殖分化过程中的应用,其特征在于,促进神经干细胞分化的过程包括降低Notch-1、Hes-1和Hes-5蛋白的表达。The use of the DNA tetrahedron according to claim 2 for promoting proliferation and differentiation of neural stem cells, characterized in that the process of promoting differentiation of neural stem cells comprises reducing the expression of Notch-1, Hes-1 and Hes-5 proteins.
- 根据权利要求2所述的DNA四面体在促进神经干细胞增殖分化过程中的应用,其特征在于,促进神经干细胞分化的过程包括促进β-III-Tubulin蛋白的表达。The use of the DNA tetrahedron according to claim 2 for promoting proliferation and differentiation of neural stem cells, characterized in that the process of promoting differentiation of neural stem cells comprises promoting expression of β-III-Tubulin protein.
- 根据权利要求2所述的DNA四面体在促进神经干细胞增殖分化过程中的应用,其特征在于,促进神经干细胞分化的过程分别包括抑制Notch-1、Hes-1和Hes-5基因的表达,以及促进β-III-Tubulin基因的表达。The use of the DNA tetrahedron according to claim 2 for promoting proliferation and differentiation of neural stem cells, characterized in that the process of promoting differentiation of neural stem cells comprises inhibiting expression of Notch-1, Hes-1 and Hes-5 genes, respectively. Promotes the expression of the β-III-Tubulin gene.
- 根据权利要求2所述的DNA四面体在促进神经干细胞增殖分化过程中的应用,其特征在于,所述DNA四面体在促进神经干细胞增殖分化过程中的浓度 为50~500nM。The use of the DNA tetrahedron according to claim 2 for promoting proliferation and differentiation of neural stem cells, characterized in that the concentration of the DNA tetrahedron in promoting proliferation and differentiation of neural stem cells is 50 to 500 nM.
- 根据权利要求8所述的DNA四面体在促进神经干细胞增殖分化过程中的应用,其特征在于,所述DNA四面体在促进神经干细胞增殖分化过程中的浓度为100~300nM。The DNA tetrahedron according to claim 8, wherein the concentration of the DNA tetrahedron in promoting proliferation and differentiation of neural stem cells is 100 to 300 nM.
- 根据权利要求8所述的DNA四面体在促进神经干细胞增殖分化过程中的应用,其特征在于,所述DNA四面体在促进神经干细胞增殖分化过程中的浓度为250nM。The use of the DNA tetrahedron according to claim 8 for promoting proliferation and differentiation of neural stem cells, characterized in that the concentration of the DNA tetrahedron in promoting proliferation and differentiation of neural stem cells is 250 nM.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711173678.XA CN107881149A (en) | 2017-11-22 | 2017-11-22 | Application of the DNA tetrahedrons during differentiation and proliferation of neural stem cells is promoted |
CN201711173678.X | 2017-11-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019100726A1 true WO2019100726A1 (en) | 2019-05-31 |
Family
ID=61778050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2018/094561 WO2019100726A1 (en) | 2017-11-22 | 2018-07-04 | Application of d dna tetrahedron in promoting proliferation and differentiation of neural stem cells |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN107881149A (en) |
WO (1) | WO2019100726A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107881149A (en) * | 2017-11-22 | 2018-04-06 | 四川大学 | Application of the DNA tetrahedrons during differentiation and proliferation of neural stem cells is promoted |
CN109806275B (en) * | 2017-11-22 | 2021-04-23 | 成都腾达树纳米生物科技有限公司 | Application of DNA tetrahedron in preparation of nerve repair promoting medicine |
CN109646450B (en) * | 2019-01-31 | 2021-03-12 | 成都腾达树纳米生物科技有限公司 | Application of DNA tetrahedron in preparation of medicine for treating corneal injury |
CN111991412B (en) * | 2020-09-30 | 2021-11-05 | 四川大学 | Medicine for treating Parkinson's disease |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007122405A1 (en) * | 2006-04-20 | 2007-11-01 | Isis Innovation Limited | Polyhedral nanostructures formed from nucleic acids |
US20140255307A1 (en) * | 2013-03-07 | 2014-09-11 | Korea Institute Of Science And Technology | Contrast medium composition and method of bio imagination using the same |
CN106497919A (en) * | 2016-11-02 | 2017-03-15 | 四川大学 | A kind of DNA tetrahedrons of aptamer AS1411 modifications and preparation method thereof |
CN106540268A (en) * | 2016-11-02 | 2017-03-29 | 四川大学 | A kind of TDNs AS1411 nucleic acid drugs composite nano materials drug-loading system and preparation method thereof |
CN107881149A (en) * | 2017-11-22 | 2018-04-06 | 四川大学 | Application of the DNA tetrahedrons during differentiation and proliferation of neural stem cells is promoted |
-
2017
- 2017-11-22 CN CN201711173678.XA patent/CN107881149A/en active Pending
-
2018
- 2018-07-04 WO PCT/CN2018/094561 patent/WO2019100726A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007122405A1 (en) * | 2006-04-20 | 2007-11-01 | Isis Innovation Limited | Polyhedral nanostructures formed from nucleic acids |
US20140255307A1 (en) * | 2013-03-07 | 2014-09-11 | Korea Institute Of Science And Technology | Contrast medium composition and method of bio imagination using the same |
CN106497919A (en) * | 2016-11-02 | 2017-03-15 | 四川大学 | A kind of DNA tetrahedrons of aptamer AS1411 modifications and preparation method thereof |
CN106540268A (en) * | 2016-11-02 | 2017-03-29 | 四川大学 | A kind of TDNs AS1411 nucleic acid drugs composite nano materials drug-loading system and preparation method thereof |
CN107881149A (en) * | 2017-11-22 | 2018-04-06 | 四川大学 | Application of the DNA tetrahedrons during differentiation and proliferation of neural stem cells is promoted |
Non-Patent Citations (2)
Title |
---|
DONG SHIBIAO: "DNA", THE DNA TETRAHEDRON NANOSTRUCTURE MATERIALS AND THEIR APPLICATIONS, vol. 27, no. 9, 25 August 2015 (2015-08-25), pages 1191 - 1197 * |
SHAO, X. R.: "Tetrahedral DNA Nanostructure: A Potential Promoter for Car- tilage Tissue Regeneration via Regulating Chondrocyte Phenotype and Prolife- ration", SMALL., vol. 1602770, 23 January 2017 (2017-01-23), XP055613743 * |
Also Published As
Publication number | Publication date |
---|---|
CN107881149A (en) | 2018-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2019100726A1 (en) | Application of d dna tetrahedron in promoting proliferation and differentiation of neural stem cells | |
WO2019101116A1 (en) | Uses of dna tetrahedron for preparing drug for promoting neural repair | |
Ge et al. | Extracellular vesicles derived from hypoxia-preconditioned olfactory mucosa mesenchymal stem cells enhance angiogenesis via miR-612 | |
WO2019100727A1 (en) | Uses of dna tetrahedron for inhibiting alzheimer's disease | |
Kang et al. | Molecular beacon-based bioimaging of multiple microRNAs during myogenesis | |
CN112587544B (en) | Use of DNA tetrahedral frame nucleic acid in preparing medicine for treating fibrosis disease | |
CN103028119A (en) | Application of miR-132 in preparation of drug for treating parkinsonism | |
CN111718995B (en) | Biomarker for nasopharyngeal carcinoma metastasis diagnosis and/or prognosis evaluation | |
Tian et al. | A cell culture condition that induces the mesenchymal-epithelial transition of dedifferentiated porcine retinal pigment epithelial cells | |
Katoh et al. | Enhanced miRNA-140 expression of osteoarthritis-affected human chondrocytes cultured in a polymer based three-dimensional (3D) matrix | |
JPWO2018235899A1 (en) | Method for culturing muscle satellite cells | |
Thomsen et al. | Traumatic brain injury reveals novel cell lineage relationships within the subventricular zone | |
CN103773890B (en) | Differentiate a complete set of chromosomal method of cotton A genome and A sub-genome | |
Stojkovic et al. | Polystyrene nanoplastics affect transcriptomic and epigenomic signatures of human fibroblasts and derived induced pluripotent stem cells: Implications for human health | |
CN109988765B (en) | Targeting inhibitor of FENDRR gene and application thereof | |
CN111518769A (en) | Method for establishing crizotinib acquired drug-resistant lung adenocarcinoma cell line | |
KR101286154B1 (en) | Composition for Promoting Chondrogenesis from Stem Cells and Anti-Tumor Composition Comprising Anti-sense Oligonucleotides | |
Eriksen et al. | Protocols for SARS-CoV-2 infection in primary ocular cells and eye organoids | |
CN102277427A (en) | Application of miR-200b in preparing medicament for treating fibrosis in inflammatory bowel disease | |
KR101927586B1 (en) | Method for Culturing Cornea Epithelial Cell by Inducing Differentiation of Induced Pluripotent Stem Cell Using miRNA and System for the Same | |
Li et al. | Adult rat hippocampus soluble factors: A novel transplantation model mimicking intracranial microenvironment for tracing the induction and differentiation of adipose-derived stromal cells in vitro | |
CN110358765A (en) | Inhibit siRNA and its application of people TNFAIP1 gene expression | |
CN105368834B (en) | MiRNA-199a inhibit sarcoblast into the application in fat differentiation agents | |
CN110093419A (en) | Application, kit and the pharmaceutical composition of circular rna and its application | |
Todorova et al. | miR-204 shifts the epithelial to mesenchymal transition in concert with the transcription factors RUNX2, ETS1, and cMYB in prostate cancer cell line model |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18880897 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18880897 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18880897 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 25/11/2020) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18880897 Country of ref document: EP Kind code of ref document: A1 |